(no subject)
Sep. 27th, 2004 02:16 pm![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
novapsycheLong Trip for Psychedelic Drugs
Psychedelic drugs are inching their way slowly but surely toward prescription status in the United States, thanks to a group of persistent scientists who believe drugs like ecstasy and psilocybin can help people with terminal cancer, obsessive-compulsive disorder and post-traumatic stress disorder, to name just a few.
The Heffter Research Institute, the Multidisciplinary Association for Psychedelic Studies and others have managed to persuade the Food and Drug Administration to approve a handful of clinical trials using psychedelics. The movement seems to be gaining ground in recent years. Since 2001, the FDA and the Drug Enforcement Administration have given the go-ahead to three clinical trials testing psychedelics on symptomatic patients, and several more are on deck.
Psychedelic drugs are inching their way slowly but surely toward prescription status in the United States, thanks to a group of persistent scientists who believe drugs like ecstasy and psilocybin can help people with terminal cancer, obsessive-compulsive disorder and post-traumatic stress disorder, to name just a few.
The Heffter Research Institute, the Multidisciplinary Association for Psychedelic Studies and others have managed to persuade the Food and Drug Administration to approve a handful of clinical trials using psychedelics. The movement seems to be gaining ground in recent years. Since 2001, the FDA and the Drug Enforcement Administration have given the go-ahead to three clinical trials testing psychedelics on symptomatic patients, and several more are on deck.
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png){kind=small}
(no subject)
Date: 2004-09-27 05:56 pm (UTC)(no subject)
Date: 2004-09-27 07:32 pm (UTC)